Doubling of Decipher Biopsy Genomic Score Is Related to Disease Reclassification on Subsequent Surveillance Biopsy but Not Adverse Features on Radical Prostatectomy

Doubling of Decipher Biopsy Genomic Score Is Related to Disease Reclassification on Subsequent Surveillance Biopsy but Not Adverse Features on Radical Prostatectomy

The utility of serial Decipher biopsy scores in a true active surveillance population is still unknown. In a man on active surveillance for low-risk prostate cancer, a doubling of the Decipher biopsy score within genomic low-risk category from first to the second biopsy related to biopsy reclassific...

Full description

Saved in:
Bibliographic Details
Main Authors: Kamyar Ghabili, Nathan Paulson, Jamil S. Syed, Cayce B. Nawaf, Ghazal Khajir, Darryl T. Martin, John Onofrey, Michael S. Leapman, Angelique Levi, Jeffrey C. Weinreb, Peter A. Humphrey, Preston C. Sprenkle
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Case Reports in Urology
Online Access:http://dx.doi.org/10.1155/2021/2687416
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://dx.doi.org/10.1155/2021/2687416

Similar Items